Specifically, among patients with colon cancer, only 6 out of 617 cases (0.96%) with multiple PIK3CA mutations exhibited PTEN mutations compared with 6 out of 90 cases (6.67%) with a single PIK3CA mutation. This evidence concerns the gene PIK3CA and colonic neoplasm.